Cholesteryl ester transfer protein inhibition to reduce cardiovascular risk: where are we now?
Trends in Pharmacological Sciences2011Vol. 32(12), pp. 694–699
Citations Over TimeTop 10% of 2011 papers
Related Papers
- The use of dyslipidemic hamsters to evaluate drug-induced alterations in reverse cholesterol transport.(2010)
- Reverse cholesterol transport and future pharmacological approaches to the treatment of atherosclerosis.(2001)
- → Reverse cholesterol transport in diabetes mellitus(2000)50 cited
- → Cholesteryl Ester Transfer Protein Inhibition(2006)14 cited
- → Impairment of Reverse Cholesterol Transport System and Atherosclerosis(2000)1 cited